Daytime sleepiness, also known as hypersomnolence, is common among patients receiving maintenance dialysis and following successful kidney transplantation. Sleepiness may be secondary to medical comorbid conditions, medication side effect, insufficient sleep syndrome, and sleep-disordered breathing or the result of a primary central disorder of hypersomnolence, such as narcolepsy. Unrecognized and untreated sleep disorders are associated with substantial morbidity and mortality among patients with end-stage kidney disease. Effective management of hypersomnolence can improve quality of life in patients with kidney disease. This review focuses on the principal causes of sleepiness in patients with end-stage kidney disease. Awareness of these disorders by treating nephrologists is crucial. This review provides a systematic approach to guide providers through the recognition, early diagnosis, and treatment of hypersomnolence, which is commonly encountered in this patient population. Areas of future research are also suggested.

中文翻译：

---

ESKD中的嗜睡症管理指南。

在接受维持性透析并成功进行肾脏移植的患者中，白天嗜睡（也称为高嗜睡）很常见。嗜睡可能是继发于医学合并症，药物副作用，睡眠综合症不足和呼吸障碍或继发于嗜睡症等原发性中枢性高嗜睡症的结果。终末期肾脏疾病患者中，无法识别和未治疗的睡眠障碍与高发病率和高死亡率相关。有效的过度睡眠管理可以改善肾脏疾病患者的生活质量。这篇综述着重于终末期肾脏疾病患者嗜睡的主要原因。通过治疗肾脏病医生了解这些疾病至关重要。这篇综述提供了一种系统的方法来指导提供者通过识别，早期诊断和治疗高嗜睡症，这在该患者人群中经常遇到。还建议了未来的研究领域。